At the CRUK Centre for Drug Development (CDD) we translate today’s science into tomorrow’s medicine. The academic, pharmaceutical and biotechnology sectors across the globe trust us to realise the full potential of their research. This is why we are the partner of choice for early phase cancer drug development.
Translate your research
Speak to our Opportunity Sourcing Team for more information and advice on how we can work together.
We fund a broad portfolio of investigator-led biotherapeutic and small molecule drug discovery, supported by an extensive core-funded infrastructure including four small molecule Drug Discovery Units and the CRUK–AstraZeneca Antibody Alliance Laboratory.
This is a joint initiative by our Experimental Cancer Medicine Centres and pharmaceutical collaborators to increase the number of clinical trials using new combinations of treatment for cancer.
Our Commercial Partnerships team work with you to develop promising ideas into successful cancer therapeutics, vaccines, diagnostics and enabling technologies.
The team can support you with specialist expertise including project development, patent filing, licensing and partnering.
Our Innovation Summit events highlight the potential of commercialisation, showcasing the benefits of translating your research and the support available to you. The events provide opportunities to network with the local entrepreneurial ecosystem and learn more about opportunities in this area.
If you're new to translating your research, our Innovation Prize can help you to identify and progress the commercial potential of your research, offering funding of up to £50,000 to support consultancy costs, business plan preparation and proof of concept experiments.
Our Opportunity Sourcing Team can advise you on the options available for translating your research and the support available from CRUK.